Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Oncgnostics GmbH

Founded as a spin-off from the University Womens' Hospital Jena, oncgnostics focuses on in vitro diagnostic tests for the early and accurate detection of cancer utilizing proprietary epigenetic biomarkers. The diagnostic products will allow earlier detection of more cancer cases and thus contribute to the improvement of therapeutic success. The initial product developed, GynTect®, allows for the rapid and reliable detection of cervical precancerous lesions and cancer. Through strategic alliances with other industry leaders, oncgnostics aims to extend its reach around the world. *


Period Start 2012-02-01 splitoff
  Predecessor University of Jena (Friedrich-Schiller-Universität Jena)
Products Industry molecular diagnostics
  Industry 2 GynTect® test
Persons Person Hansel, Alfred (Oncgnostics GmbH 201204 Managing Director + Co-founder)
  Person 2 Schmitz, Martina (Oncgnostics GmbH 201204 Managing Director + Co-founder)
Region Region Jena
  Country Germany
  Street 2 Winzerlaer Str.
  City 07745 Jena
  Tel +49-3641-508456
    Address record changed: 2020-12-02
Basic data Employees A: 1 to 10 (2017-09-07)
    * Document for �About Section�: 
Record changed: 2020-03-01


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Oncgnostics GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top